No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...

There are certain phrases that Wachuka Gichohi finds difficult to hear after enduring four years of living with long COVID, ...

Chronic illness can be infuriatingly subtle, unpredictable, and impossible for anyone else to see. Eventually, after many ...

XFOR READ THE FULL XFOR RESEARCH REPORT Business Update Positive Results from Six-Month Phase 2 Trial of Mavorixafor in ...

According to research, nearly 35 percent of U.S. adults suffer from chronic inflammation, a condition that often goes ...

The most challenging part of my recent pain journey was the uncertainty. But, as uncomfortable as it is, uncertainty also ...

REM stands for rapid eye movement — a stage in the sleep cycle when your brain is almost as active as when you’re awake.

Valley fever cases are up almost 50% in Arizona in 2024. It's not contagious as a person has to be exposed to fungal spores ...

de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .

Obstructive sleep apnea has been linked to an increased risk of dementia in a new study—and the association was particularly ...

Gilead Sciences, Inc. today announced data from a two-and-a-half-year interim analysis from the ongoing Phase 3 ASSURE study, which showed that 81% (30 out of 37) of participants with primary biliary ...

Amgen today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheumatology (ACR) Convergence 2024 conference in Washington, D.C., ...